|
|
| G
|
Acp3
|
acid phosphatase 3
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ACP3 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 8:113,784,372...113,833,033
Ensembl chr 8:113,785,032...113,833,033
|
|
| G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
multiple interactions
|
ISO
|
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]
|
CTD |
PMID:32971123 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
|
|
| G
|
Agt
|
angiotensinogen
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [AGT protein results in decreased abundance of NADP]; Ellagic Acid inhibits the reaction [AGT protein results in increased activity of CASP3 protein]; Ellagic Acid inhibits the reaction [AGT protein results in increased activity of RELA protein]; Ellagic Acid inhibits the reaction [AGT protein results in increased expression of AGTR1 protein]; Ellagic Acid inhibits the reaction [AGT protein results in increased expression of CYBA mRNA]; Ellagic Acid inhibits the reaction [AGT protein results in increased expression of MYH7 mRNA]; Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NCF2 mRNA]; Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NOS2 mRNA]; Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NPPA mRNA]; Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NPPB mRNA]; Ellagic Acid inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; Ellagic Acid inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:38356441 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [AGT protein results in increased expression of AGTR1 protein]
|
CTD |
PMID:38356441 |
|
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of AIFM1 protein
|
CTD |
PMID:23554011 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
increases phosphorylation multiple interactions
|
ISO EXP
|
Ellagic Acid results in increased phosphorylation of AKT1 protein Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of AKT1 protein]
|
CTD |
PMID:26986492 PMID:35236242 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alb
|
albumin
|
multiple interactions affects binding
|
ISO
|
ALB protein promotes the reaction [Ellagic Acid results in increased activity of F12 protein] Ellagic Acid binds to ALB protein
|
CTD |
PMID:6343536 PMID:25247703 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Alkbh2
|
alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase
|
decreases activity
|
ISO
|
Ellagic Acid results in decreased activity of ALKBH2 protein
|
CTD |
PMID:31088072 |
|
NCBI chr12:48,156,825...48,161,489
Ensembl chr12:48,156,827...48,161,483
|
|
| G
|
Alpl
|
alkaline phosphatase, biomineralization associated
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ALPL mRNA
|
CTD |
PMID:38145796 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
decreases expression increases expression
|
ISO
|
Ellagic Acid results in decreased expression of APAF1 mRNA Ellagic Acid results in increased expression of APAF1 mRNA
|
CTD |
PMID:12002526 PMID:35179410 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
App
|
amyloid beta precursor protein
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Aluminum Chloride results in increased expression of APP protein]
|
CTD |
PMID:34944019 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Ascl1
|
achaete-scute family bHLH transcription factor 1
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ASCL1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ASNS mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Atf3
|
activating transcription factor 3
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ATF3 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atg5
|
autophagy related 5
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ATG5 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of BAD protein
|
CTD |
PMID:23554011 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
EXP ISO
|
Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of BAX mRNA] Ellagic Acid results in increased expression of BAX mRNA
|
CTD |
PMID:29854611 PMID:35179410 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
Ellagic Acid results in increased expression of BCL2 protein [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA] Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein]; Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mRNA] Ellagic Acid results in decreased expression of BCL2 mRNA
|
CTD |
PMID:20103723 PMID:22386815 PMID:29854611 PMID:35179410 PMID:35236242 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bmp6
|
bone morphogenetic protein 6
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of BMP6 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
|
|
| G
|
Brf1
|
BRF1 general transcription factor IIIB subunit
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of BRF1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 6:137,854,055...137,902,629
Ensembl chr 6:137,855,449...137,902,386
|
|
| G
|
Calr
|
calreticulin
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of CALR mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
| G
|
Casp3
|
caspase 3
|
increases expression decreases expression decreases activity increases activity multiple interactions
|
ISO EXP
|
Ellagic Acid results in increased expression of CASP3 mRNA Ellagic Acid results in decreased expression of CASP3 mRNA Ellagic Acid results in decreased activity of CASP3 protein Ellagic Acid results in increased activity of CASP3 protein Ellagic Acid results in increased expression of and results in increased activity of CASP3 protein Ellagic Acid inhibits the reaction [AGT protein results in increased activity of CASP3 protein]; Ellagic Acid inhibits the reaction [Aluminum Chloride results in increased expression of CASP3 protein]; Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of CASP3 protein]; Ellagic Acid inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased activity of CASP3 protein]; Ellagic Acid inhibits the reaction [Streptozocin results in increased expression of CASP3 protein]; Ellagic Acid promotes the reaction [sinapinic acid inhibits the reaction [Streptozocin results in increased expression of CASP3 protein]]; sinapinic acid promotes the reaction [Ellagic Acid inhibits the reaction [Streptozocin results in increased expression of CASP3 protein]]
|
CTD |
PMID:12002526 PMID:22386815 PMID:23554011 PMID:23811531 PMID:28815802 PMID:29854611 PMID:34661493 PMID:34944019 PMID:35236242 PMID:38356441 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
Ellagic Acid results in increased expression of and results in increased activity of CASP9 protein
|
CTD |
PMID:23554011 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
increases activity multiple interactions
|
EXP
|
Ellagic Acid results in increased activity of CAT protein Ellagic Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased activity of CAT protein]; Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein]; Ellagic Acid inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Ellagic Acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]
|
CTD |
PMID:20074268 PMID:24877639 PMID:29864931 PMID:35236242 PMID:36108929 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
decreases secretion
|
ISO
|
Ellagic Acid results in decreased secretion of CCL2 protein
|
CTD |
PMID:20816778 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccng1
|
cyclin G1
|
decreases expression
|
EXP
|
ellagic acid inhibits the reaction [estrogen increases expression of Ccng1 mRNA and protein in rat mammary tissue]
|
RGD |
PMID:23791885 |
RGD:151356928 |
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
| G
|
Cd14
|
CD14 molecule
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of CD14 mRNA
|
CTD |
PMID:20816778 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of CDK1 protein
|
CTD |
PMID:23554011 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
ISO
|
[resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA] Ellagic Acid results in increased expression of CDKN1A protein [Ellagic Acid co-treated with Quercetin] results in increased expression of CDKN1A mRNA; Ellagic Acid promotes the reaction [Quercetin results in increased expression of CDKN1A protein]; pifithrin inhibits the reaction [Ellagic Acid promotes the reaction [Quercetin results in increased expression of CDKN1A protein]]
|
CTD |
PMID:15735102 PMID:20103723 PMID:23554011 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of COL1A1 mRNA; Ellagic Acid results in increased expression of COL1A1 protein
|
CTD |
PMID:38145796 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Ctsd
|
cathepsin D
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of CTSD protein]
|
CTD |
PMID:21762681 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
|
|
| G
|
Ctsk
|
cathepsin K
|
multiple interactions
|
ISO
|
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]
|
CTD |
PMID:32971123 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [AGT protein results in increased expression of CYBA mRNA]
|
CTD |
PMID:38356441 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
decreases expression decreases activity
|
ISO
|
Ellagic Acid results in decreased expression of CYP1A1 mRNA Ellagic Acid results in decreased activity of CYP1A1 protein
|
CTD |
PMID:19329757 PMID:20816778 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
decreases activity multiple interactions
|
ISO
|
Ellagic Acid results in decreased activity of CYP1B1 protein [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]
|
CTD |
PMID:19329757 PMID:20103723 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Daxx
|
death-domain associated protein
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of DAXX mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720
|
|
| G
|
Dffa
|
DNA fragmentation factor subunit alpha
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of DFFA mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:164,823,807...164,836,728
|
|
| G
|
E4f1
|
E4F transcription factor 1
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of E4F1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr10:13,978,975...13,999,646
Ensembl chr10:13,978,990...13,990,506
|
|
| G
|
Egr3
|
early growth response 3
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of EGR3 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712
|
|
| G
|
Endog
|
endonuclease G
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ENDOG protein
|
CTD |
PMID:23554011 |
|
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573
|
|
| G
|
Ep300
|
E1A binding protein p300
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of EP300 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Eps15
|
epidermal growth factor receptor pathway substrate 15
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of EPS15 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856
|
|
| G
|
Ezh1
|
enhancer of zeste 1 polycomb repressive complex 2 subunit
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of EZH1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr10:86,626,307...86,662,257
Ensembl chr10:86,626,308...86,652,620
|
|
| G
|
F12
|
coagulation factor XII
|
multiple interactions increases activity
|
ISO
|
ALB protein promotes the reaction [Ellagic Acid results in increased activity of F12 protein]
|
CTD |
PMID:6343536 |
|
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of FGFR1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Flna
|
filamin A
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of FLNA mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr X:157,159,051...157,185,559
Ensembl chr X:157,159,051...157,182,343
|
|
| G
|
Fn1
|
fibronectin 1
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of FN1 protein]
|
CTD |
PMID:24877639 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]
|
CTD |
PMID:20103723 PMID:32971123 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
decreases activity
|
ISO
|
Ellagic Acid results in decreased activity of G6PD protein
|
CTD |
PMID:25130191 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gal
|
galanin and GMAP prepropeptide
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [phosalone results in increased activity of GAL protein]
|
CTD |
PMID:27965107 |
|
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229
|
|
| G
|
Gpld1
|
glycosylphosphatidylinositol specific phospholipase D1
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of GPLD1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr17:40,512,659...40,560,483
Ensembl chr17:40,512,660...40,554,975
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
EXP ISO
|
Ellagic Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of GPT protein]; Ellagic Acid inhibits the reaction [sodium arsenite results in increased expression of GPT protein] Ellagic Acid inhibits the reaction [Diquat results in increased activity of GPT protein]
|
CTD |
PMID:24877639 PMID:29935397 PMID:35268077 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
EXP ISO
|
Ellagic Acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mRNA] Ellagic Acid inhibits the reaction [Diquat results in decreased expression of GPX1 mRNA]
|
CTD |
PMID:29935397 PMID:35268077 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased activity of GSR protein]
|
CTD |
PMID:24877639 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gsta4
|
glutathione S-transferase alpha 4
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of GSTA4 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
affects expression
|
EXP
|
Ellagic Acid affects the expression of GSTT1 protein
|
CTD |
PMID:9855024 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
Gtf2e2
|
general transcription factor IIE subunit 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of GTF2E2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr16:65,102,386...65,152,563
Ensembl chr16:65,102,390...65,161,394
|
|
| G
|
Gtf2h4
|
general transcription factor 2H subunit 4
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of GTF2H4 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr20:3,076,110...3,081,805
Ensembl chr20:3,076,088...3,081,760
|
|
| G
|
Gusb
|
glucuronidase, beta
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Isoproterenol results in increased activity of GUSB protein]
|
CTD |
PMID:21762681 |
|
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of HIF1A mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hlcs
|
holocarboxylase synthetase
|
decreases activity
|
ISO
|
Ellagic Acid results in decreased activity of HLCS protein
|
CTD |
PMID:26303405 |
|
NCBI chr11:46,925,491...47,123,111
Ensembl chr11:46,925,491...47,105,082
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO
|
Ellagic Acid results in increased expression of HMOX1 mRNA; Ellagic Acid results in increased expression of HMOX1 protein [Paraquat co-treated with Ellagic Acid] results in increased expression of HMOX1 mRNA; [Paraquat co-treated with Ellagic Acid] results in increased expression of HMOX1 protein Ellagic Acid inhibits the reaction [Diquat results in decreased expression of HMOX1 mRNA]
|
CTD |
PMID:22386815 PMID:23546295 PMID:35268077 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hras
|
HRas proto-oncogene, GTPase
|
multiple interactions
|
ISO
|
[Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]
|
CTD |
PMID:20103723 |
|
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
|
|
| G
|
Ier2
|
immediate early response 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of IER2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708
|
|
| G
|
Ifng
|
interferon gamma
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of IFNG mRNA]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of IFNG protein]
|
CTD |
PMID:29854611 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of IGFBP2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
|
|
| G
|
Igfbp4
|
insulin-like growth factor binding protein 4
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of IGFBP4 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473
|
|
| G
|
Il1b
|
interleukin 1 beta
|
decreases expression multiple interactions
|
ISO EXP
|
Ellagic Acid results in decreased expression of IL1B mRNA Ellagic Acid inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of IL1B mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of IL1B protein]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of IL1B mRNA]; Ellagic Acid inhibits the reaction [sodium arsenite results in increased expression of IL1B protein]
|
CTD |
PMID:18377686 PMID:20816778 PMID:21762681 PMID:24877639 PMID:27965107 PMID:29455002 PMID:29854611 PMID:29864931 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1r1
|
interleukin 1 receptor type 1
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of IL1R1 mRNA
|
CTD |
PMID:20816778 |
|
NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of IL6 protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of IL6 protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of IL6 mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of IL6 protein]
|
CTD |
PMID:21762681 PMID:24877639 PMID:27965107 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of INPP5D mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589
|
|
| G
|
Iqgap2
|
IQ motif containing GTPase activating protein 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of IQGAP2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649
|
|
| G
|
Irf9
|
interferon regulatory factor 9
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of IRF9 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:33,065,659...33,071,879
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of JUN mRNA; Ellagic Acid results in decreased expression of JUN protein modified form
|
CTD |
PMID:23811531 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Klk1c10
|
kallikrein 1-related peptidase C10
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of KLK3 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
|
|
| G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of LITAF mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
|
|
| G
|
Map1a
|
microtubule-associated protein 1A
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of MAP1A mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 3:128,716,907...128,736,638
Ensembl chr 3:128,716,940...128,740,159
|
|
| G
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of MAP3K1 mRNA; Ellagic Acid results in decreased expression of MAP3K1 protein
|
CTD |
PMID:23811531 |
|
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO EXP
|
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein] Ellagic Acid inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:32971123 PMID:38356441 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk11
|
mitogen-activated protein kinase 11
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of MAPK11 mRNA
|
CTD |
PMID:23811531 |
|
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [phosalone results in increased expression of MAPK14 protein]
|
CTD |
PMID:27965107 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO EXP
|
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] Ellagic Acid inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:32971123 PMID:38356441 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
ISO
|
[Ellagic Acid co-treated with Quercetin] results in increased phosphorylation of MAPK8 protein
|
CTD |
PMID:15735102 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
ISO
|
[Ellagic Acid co-treated with Quercetin] results in increased phosphorylation of MAPK9 protein
|
CTD |
PMID:15735102 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
decreases activity
|
EXP
|
Ellagic Acid results in decreased activity of MGST1 protein
|
CTD |
PMID:16125204 |
|
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875
|
|
| G
|
Mir140
|
microRNA 140
|
multiple interactions
|
EXP
|
ellagic acid inhibits the reaction [hypoxia and acute myocardial infarction decreases expression of mir140 RNA in cardiac muscle cells]
|
RGD |
PMID:28922712 |
RGD:329347824 |
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:52,375,293...52,375,391
|
|
| G
|
Mmd
|
monocyte to macrophage differentiation-associated
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of MMD mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr10:75,570,366...75,598,610
Ensembl chr10:75,570,397...75,598,609
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
multiple interactions decreases activity decreases expression
|
ISO
|
Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein; zinc chloride inhibits the reaction [Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein] Ellagic Acid results in decreased activity of MMP2 protein Ellagic Acid results in decreased expression of MMP2 mRNA
|
CTD |
PMID:21573219 PMID:35179410 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
decreases expression decreases activity
|
ISO
|
Ellagic Acid results in decreased expression of MMP9 mRNA Ellagic Acid results in decreased activity of MMP9 protein
|
CTD |
PMID:35179410 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Myh7
|
myosin heavy chain 7
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [AGT protein results in increased expression of MYH7 mRNA]
|
CTD |
PMID:38356441 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194
|
|
| G
|
Ncf2
|
neutrophil cytosolic factor 2
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NCF2 mRNA]
|
CTD |
PMID:38356441 |
|
NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149
|
|
| G
|
Nfatc1
|
nuclear factor of activated T-cells 1
|
multiple interactions
|
ISO
|
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]
|
CTD |
PMID:32971123 |
|
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
affects localization affects response to substance increases expression multiple interactions
|
ISO EXP
|
Ellagic Acid affects the localization of NFE2L2 protein NFE2L2 protein affects the susceptibility to Ellagic Acid Ellagic Acid results in increased expression of NFE2L2 mRNA; Ellagic Acid results in increased expression of NFE2L2 protein [Paraquat co-treated with Ellagic Acid] results in increased expression of and affects the localization of NFE2L2 protein; [Paraquat co-treated with Ellagic Acid] results in increased expression of NFE2L2 mRNA; Ellagic Acid results in increased expression of and affects the localization of NFE2L2 protein [Ellagic Acid co-treated with Diquat] results in increased expression of NFE2L2 mRNA; Ellagic Acid inhibits the reaction [Diquat results in decreased expression of NFE2L2 mRNA]; Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mRNA] Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 protein]
|
CTD |
PMID:22386815 PMID:23546295 PMID:30503583 PMID:35236242 PMID:35268077 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb2
|
nuclear factor kappa B subunit 2
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of NFKB2 mRNA
|
CTD |
PMID:12002526 PMID:35179410 |
|
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
|
|
| G
|
Nnat
|
neuronatin
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of NNAT mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:166,646,384...166,649,086
|
|
| G
|
Nop56
|
NOP56 ribonucleoprotein
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of NOP56 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 3:137,926,187...137,934,971
Ensembl chr 3:137,929,646...137,934,959
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions decreases expression
|
EXP ISO
|
Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NOS2 mRNA]; Ellagic Acid inhibits the reaction [Doxorubicin results in increased expression of NOS2 protein] Ellagic Acid results in decreased expression of NOS2 mRNA
|
CTD |
PMID:28815802 PMID:35179410 PMID:38356441 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Npas2
|
neuronal PAS domain protein 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of NPAS2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 9:48,959,225...49,138,036
Ensembl chr 9:48,959,148...49,138,037
|
|
| G
|
Nppa
|
natriuretic peptide A
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NPPA mRNA]
|
CTD |
PMID:38356441 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nppb
|
natriuretic peptide B
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [AGT protein results in increased expression of NPPB mRNA]
|
CTD |
PMID:38356441 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression multiple interactions
|
ISO
|
Ellagic Acid results in increased expression of NQO1 mRNA; Ellagic Acid results in increased expression of NQO1 protein [Paraquat co-treated with Ellagic Acid] results in increased expression of NQO1 mRNA; [Paraquat co-treated with Ellagic Acid] results in increased expression of NQO1 protein Ellagic Acid inhibits the reaction [Diquat results in decreased expression of NQO1 mRNA]
|
CTD |
PMID:23546295 PMID:35268077 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases activity
|
ISO
|
Ellagic Acid results in increased activity of NR1I3 protein
|
CTD |
PMID:21821919 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
| G
|
Parg
|
poly (ADP-ribose) glycohydrolase
|
decreases activity
|
ISO
|
Ellagic Acid results in decreased activity of PARG protein
|
CTD |
PMID:19840838 |
|
NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,442,726...7,550,584
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]
|
CTD |
PMID:25247703 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions
|
ISO
|
[resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]
|
CTD |
PMID:20103723 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pdia2
|
protein disulfide isomerase family A, member 2
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein]
|
CTD |
PMID:25247703 |
|
NCBI chr10:15,720,301...15,723,386
Ensembl chr10:15,720,301...15,723,396
|
|
| G
|
Pgd
|
phosphogluconate dehydrogenase
|
decreases activity
|
ISO
|
Ellagic Acid results in decreased activity of PGD protein
|
CTD |
PMID:25130191 |
|
NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029
|
|
| G
|
Pla2g2a
|
phospholipase A2 group IIA
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of PLA2G2A mRNA
|
CTD |
PMID:20816778 |
|
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297
|
|
| G
|
Plp2
|
proteolipid protein 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of PLP2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr X:17,506,153...17,509,552
Ensembl chr X:17,506,059...17,509,550
|
|
| G
|
Pml
|
PML nuclear body scaffold
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of PML mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083
|
|
| G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of PPARD mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of PPARG protein
|
CTD |
PMID:23811531 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions decreases expression
|
ISO
|
Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of PPARGC1A mRNA] Ellagic Acid results in decreased expression of PPARGC1A mRNA
|
CTD |
PMID:30503583 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Prkg1
|
protein kinase cGMP-dependent 1
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of PRKG1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:237,823,053...239,103,005
|
|
| G
|
Ptn
|
pleiotrophin
|
decreases expression increases expression
|
ISO
|
Ellagic Acid results in decreased expression of PTN mRNA Ellagic Acid results in increased expression of PTN mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482
|
|
| G
|
Ptprn2
|
protein tyrosine phosphatase, receptor type N2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of PTPRN2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 6:143,582,568...144,334,573
Ensembl chr 6:143,582,547...144,336,744
|
|
| G
|
Ran
|
RAN, member RAS oncogene family
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of RAN mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317
|
|
| G
|
Rb1
|
RB transcriptional corepressor 1
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [phosalone results in increased expression of RB1 mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of RB1 protein]
|
CTD |
PMID:27965107 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
|
|
| G
|
Reck
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
increases expression multiple interactions
|
ISO
|
Ellagic Acid results in increased expression of RECK mRNA; Ellagic Acid results in increased expression of RECK protein zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK mRNA]; zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK protein]
|
CTD |
PMID:21573219 |
|
NCBI chr 5:62,898,717...62,965,274
Ensembl chr 5:62,898,668...62,965,270
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
decreases expression multiple interactions
|
ISO EXP
|
Ellagic Acid results in decreased expression of RELA mRNA Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of RELA protein]; Ellagic Acid inhibits the reaction [AGT protein results in increased activity of RELA protein]; Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of RELA protein]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of RELA protein] Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of RELA protein] Ellagic Acid inhibits the reaction [TNF protein affects the localization of and results in increased activity of RELA protein]
|
CTD |
PMID:12002526 PMID:24877639 PMID:27473819 PMID:27965107 PMID:32971123 PMID:35236242 PMID:38356441 More...
|
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rgs5
|
regulator of G-protein signaling 5
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of RGS5 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr13:84,381,077...84,417,875
Ensembl chr13:84,380,910...84,421,352
|
|
| G
|
Runx2
|
RUNX family transcription factor 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of RUNX2 mRNA; Ellagic Acid results in increased expression of RUNX2 protein
|
CTD |
PMID:38145796 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of SCD mRNA
|
CTD |
PMID:20816778 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Septin2
|
septin 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of SEPTIN2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 9:101,465,535...101,498,766
Ensembl chr 9:101,465,650...101,498,759
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Aluminum Chloride results in decreased expression of SOD1 mRNA]; Ellagic Acid inhibits the reaction [Aluminum Chloride results in decreased expression of SOD1 protein]
|
CTD |
PMID:34944019 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA]
|
CTD |
PMID:29935397 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of SOD3 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Sp7
|
Sp7 transcription factor
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of SP7 mRNA; Ellagic Acid results in increased expression of SP7 protein
|
CTD |
PMID:38145796 |
|
NCBI chr 7:135,363,193...135,373,376
Ensembl chr 7:135,363,199...135,373,559
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of SPP1 mRNA; Ellagic Acid results in increased expression of SPP1 protein
|
CTD |
PMID:38145796 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions
|
ISO
|
Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC protein]
|
CTD |
PMID:32971123 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
increases expression multiple interactions
|
ISO
|
Ellagic Acid results in increased expression of STAR mRNA Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of STAR mRNA]
|
CTD |
PMID:30503583 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
increases expression decreases expression
|
ISO
|
Ellagic Acid results in increased expression of STAT3 mRNA Ellagic Acid results in decreased expression of STAT3 mRNA
|
CTD |
PMID:12002526 PMID:20816778 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Taf1c
|
TATA-box binding protein associated factor, RNA polymerase 1 subunit C
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of TAF1C mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr19:64,561,079...64,567,599
Ensembl chr19:64,560,562...64,567,599
|
|
| G
|
Tcf12
|
transcription factor 12
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of TCF12 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 8:81,371,201...81,682,337
Ensembl chr 8:81,373,321...81,679,922
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
multiple interactions increases expression
|
ISO EXP
|
Ellagic Acid inhibits the reaction [Estradiol results in increased expression of TERT mRNA alternative form] Ellagic Acid results in increased expression of TERT mRNA alternative form Ellagic Acid inhibits the reaction [phosalone results in decreased activity of TERT protein]
|
CTD |
PMID:19501078 PMID:27965107 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tfam
|
transcription factor A, mitochondrial
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of TFAM mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression multiple interactions
|
ISO EXP
|
Ellagic Acid results in increased expression of TGFB1 mRNA Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of TGFB1 protein]
|
CTD |
PMID:12002526 PMID:24877639 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions decreases expression
|
EXP ISO
|
Ellagic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [chromium hexavalent ion results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [Glucose results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of TNF mRNA]; Ellagic Acid inhibits the reaction [sodium arsenate results in increased expression of TNF protein]; Ellagic Acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein] Ellagic Acid results in decreased expression of TNF mRNA Ellagic Acid inhibits the reaction [TNF protein affects the localization of and results in increased activity of RELA protein]; Ellagic Acid inhibits the reaction [TNF protein results in increased activity of and affects the secretion of CXCL8 protein]
|
CTD |
PMID:21762681 PMID:24877639 PMID:27473819 PMID:27965107 PMID:28815802 PMID:29455002 PMID:29854611 PMID:29864931 PMID:35179410 PMID:35236242 PMID:36108929 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf11a
|
TNF receptor superfamily member 11A
|
multiple interactions affects binding
|
ISO
|
Ellagic Acid inhibits the reaction [TNFSF11 protein binds to TNFRSF11A protein] Ellagic Acid binds to TNFRSF11A protein
|
CTD |
PMID:32971123 |
|
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:22,442,665...22,501,257
|
|
| G
|
Tnfsf11
|
TNF superfamily member 11
|
multiple interactions affects binding
|
ISO
|
Ellagic Acid inhibits the reaction [TNFSF11 protein binds to TNFRSF11A protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of SRC protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased phosphorylation of RELA protein] Ellagic Acid binds to TNFSF11 protein
|
CTD |
PMID:32971123 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Isoproterenol results in increased expression of TNNT2 protein]
|
CTD |
PMID:21762681 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression multiple interactions
|
ISO EXP
|
Ellagic Acid results in increased expression of TP53 mRNA; Ellagic Acid results in increased expression of TP53 protein Ellagic Acid inhibits the reaction [phosalone results in increased expression of TP53 mRNA]; Ellagic Acid inhibits the reaction [phosalone results in increased expression of TP53 protein] Ellagic Acid promotes the reaction [Quercetin results in increased phosphorylation of TP53 protein]; pifithrin inhibits the reaction [Ellagic Acid promotes the reaction [Quercetin results in increased phosphorylation of TP53 protein]]
|
CTD |
PMID:15735102 PMID:23554011 PMID:27965107 PMID:35179410 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Ugp2
|
UDP-glucose pyrophosphorylase 2
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of UGP2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr14:99,657,637...99,698,573
Ensembl chr14:99,657,639...99,698,002
|
|
| G
|
Usp4
|
ubiquitin specific peptidase 4
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of USP4 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 8:117,912,576...117,957,934
Ensembl chr 8:117,914,614...117,957,949
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions
|
EXP
|
Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of VEGFA protein]
|
CTD |
PMID:35236242 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Wars1
|
tryptophanyl-tRNA synthetase 1
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of WARS1 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645
|
|
| G
|
Wee1
|
WEE1 G2 checkpoint kinase
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of WEE1 protein
|
CTD |
PMID:23554011 |
|
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449
|
|
| G
|
Zbtb16
|
zinc finger and BTB domain containing 16
|
decreases expression
|
ISO
|
Ellagic Acid results in decreased expression of ZBTB16 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507
|
|
| G
|
Zmym2
|
zinc finger MYM-type containing 2
|
increases expression
|
ISO
|
Ellagic Acid results in increased expression of ZMYM2 mRNA
|
CTD |
PMID:12002526 |
|
NCBI chr15:35,151,356...35,224,528
Ensembl chr15:35,127,994...35,224,941
|
|